No Data
No Data
Trump Renews Push for Most-Favored-Nation Drug Pricing. What It All Means
Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency'
J.P. Morgan Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating
Neurocrine Biosciences, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Express News | Neurocrine Biosciences Inc - Data Consistent Across All Patient Subgroups in Cahtalyst Study
Express News | Neurocrine Biosciences Announces New Results From Exploratory Analyses of the Phase 3 Cahtalyst™ Pediatric Study Demonstrating Crenessity™ Reduces Glucocorticoid Dosing While Maintaining or Improving Androstenedione Across Patient Subgroups